Ang-1 and soluble Tie-2 expression were associated with disease severity in Ugandan children with severe malaria, and therapeutic Ang-1 improved survival in a murine model.
Observational
Cerebral malaria is a leading cause of global morbidity and mortality. Interventions targeting the underlying pathophysiology of cerebral malaria may improve outcomes compared to treatment with antimalarials alone. Microvascular leak plays an important role in the pathogenesis of cerebral malaria. The angiopoietin (Ang)-Tie-2 system is a critical regulator of vascular function. We show that Ang-1 expression and soluble Tie-2 expression were associated with disease severity and outcome in a prospective study of Ugandan children with severe malaria and in a preclinical murine model of experimental cerebral malaria. Ang-1 was necessary for maintenance of vascular integrity and survival in a mouse model of cerebral malaria. Therapeutic administration of Ang-1 preserved blood-brain barrier integrity and, in combination with artesunate treatment, improved survival beyond that with artesunate alone. These data define a role for dysregulation of the Ang-Tie-2 axis in the pathogenesis of cerebral malaria and support the evaluation of Ang-Tie-2-based interventions as potential adjunctive therapies for treating severe malaria.
Higgins et al. (Wed,) conducted a observational in Severe malaria. Ang-1 and soluble Tie-2 expression was evaluated on Disease severity and outcome. Ang-1 and soluble Tie-2 expression were associated with disease severity in Ugandan children with severe malaria, and therapeutic Ang-1 improved survival in a murine model.